The Week in Review: September 15, 2017 – September 22, 2017
Epclusa approved for HIV-HCV coinfection in Canada, generic sofosbuvir approved in Malaysia, unrestricted access to Epclusa and Harvoni in Switzerland, new study on financial burden of liver disease, predictors of fibrosis progression in HBV……..
The Week in Review: September 8, 2017 – September 15, 2017
Rosemary Plummer steps down as President of HepCBC; rest of the Board re-elected at AGM; Women and HCV; How Liver Cancer Develops; Global Burden of Disease, Johnson & Johnson pulls plug on Medivir-Achillion hep C cocktail to focus on hep B……..
The Week in Review: September 1, 2017 – September 8, 2017
Mystery illness solved, DAAs and kidney disease, drug paraphernalia and transmission, fibrosis progression in men and the last word on DAAs and HCC?